Arun Bhandari, MD, has been a practicing Oncologist and Hematologist at Chesapeake Oncology Hematology Associates, PA (COHA), Annapolis, MD since 2007 (an Oncology - Hematology private practice serving citizens of Maryland since 1990). He is on staff at Anne Arundel Medical Center (AAMC), Baltimore Washington Medical Center (BWMC), and John Hopkins Medicine at Howard County General Hospital (HCGH). Dr. Bhandari is an Executive Board Member of The Maryland and District of Columbia Society Of Clinical Oncology, Inc. (MDCSCO), which plays a significant role in improving the quality and delivery of cancer care in Maryland and the District of Columbia.

Bhandari was appointed by Governor Hogan as a Council on the Maryland State Council on Cancer Control, where his role is to educate and advise government officials, public and private organizations, and the general public on comprehensive State policies and programs necessary to reduce and control cancer incidence, mortality, and morbidity among Marylanders. Dr. Bhandari served as a member of the Maryland Board of Physicians from 2016 to 2020. He served as Chairman of Panel A of the Board from May 2016 until April 2020, where he was responsible for assuring quality health care in Maryland through the efficient licensure and effective discipline of healthcare providers under its jurisdiction by protecting and educating clients, customers, and stakeholders, and by enforcing the Maryland Medical Practice Act.

Dr. Bhandari completed a fellowship in Hematology-Oncology from Georgetown University Hospital/Washington Hospital Center, Washington, DC with bone marrow transplant rotation at the National Institute of Health (NIH- NHLBI), Bethesda, MD. He served as a Chief Fellow in Hematology & Oncology from 2004-2005. He was a fellow in Hematology & Oncology at The University of Tennessee Health Science Center, Memphis, TN, and NCCN Member Institution.